NASDAQ : INBS
Intelligent Bio Solutions Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 1.83 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 5.54M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 5.33M |
| Enterprise Value | 3.01M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 16, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 3.03M |
| Shares Outstanding | 3.03M |
| Shares Change (YoY) | +179.27% |
| Shares Change (QoQ) | +56.86% |
| Owned by Insiders (%) | 2.99% |
| Owned by Institutions (%) | 6.07% |
| Float | 2.94M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.26 |
| Forward PS | 0.87 |
| PB Ratio | 0.93 |
| P/TBV Ratio | 1.96 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 0.71 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.44 |
| Quick Ratio | 1.18 |
| Debt / Equity | 0.34 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,146.57 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -307.69% |
| Return on Assets (ROA) | -76.20% |
| Return on Invested Capital (ROIC) | -150.77% |
| Return on Capital Employed (ROCE) | -175.53% |
| Weighted Average Cost of Capital (WACC) | 20.93% |
| Revenue Per Employee | $70,253 |
| Profits Per Employee | -$207,183 |
| Employee Count | 60 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 4.11 |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 4.30 |
| 52-Week Price Change | -81.50% |
| 50-Day Moving Average | 1.88 |
| 200-Day Moving Average | 3.17 |
| Relative Strength Index (RSI) | 53.23 |
| Average Volume (20 Days) | 42,474 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 91,113 |
| Short Previous Month | 58,294 |
| Short % of Shares Out | 3.01% |
| Short % of Float | 3.10% |
| Short Ratio (days to cover) | 1.75 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 4.22M |
| Gross Profit | 2.05M |
| Operating Income | -12.31M |
| Pretax Income | -12.47M |
| Net Income | -12.43M |
| EBITDA | -11.15M |
| EBIT | -12.31M |
| Loss Per Share | -$8.44 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 4.14M |
| Total Debt | 1.82M |
| Net Cash | 2.32M |
| Net Cash Per Share | $0.77 |
| Equity (Book Value) | 5.29M |
| Book Value Per Share | 1.90 |
| Working Capital | 2.17M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -11.93M |
| Capital Expenditures | -125,731 |
| Depreciation & Amortization | 1.16M |
| Net Borrowing | n/a |
| Free Cash Flow | -12.05M |
| FCF Per Share | -$3.98 |
Margins
| Measure | Value |
|---|
| Gross Margin | 48.63% |
| Operating Margin | -292.03% |
| Pretax Margin | -295.80% |
| Profit Margin | -294.91% |
| EBITDA Margin | -264.42% |
| EBIT Margin | -292.03% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -179.27% |
| Shareholder Yield | -179.27% |
| Earnings Yield | -479.58% |
| FCF Yield | -226.20% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 43.09% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Dec 16, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -10.81 |
| Piotroski F-Score | 4 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |